Redhill Biopharma
Quarterly Financials
| Values in thousands | 2023-06-30 | 2023-03-31 | 2022-12-31 |
|---|---|---|---|
Revenue | $1,796 | $12,798 | $12,798 |
Gross Profit | 990 | 4,200 | 4,200 |
EBITDA | 2,687 | 757 | -294 |
EBIT | 1,574 | -1,244 | -9,948 |
Net Income | 761 | 2,490 | 2,490 |
Net Change In Cash | 1,796 | 12,798 | 12,798 |
Free Cash Flow | -10,596 | -2,422 | -2,421 |
Cash | 6,996 | 19,968 | 19,968 |
Basic Shares | 157 | 2,329 | 1,548 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $6,513 | $61,800 | $85,757 | $64,359 |
Gross Profit | 3,054 | 28,463 | 36,351 | 27,467 |
EBITDA | 26,266 | -42,844 | -63,028 | -54,939 |
EBIT | 24,276 | -50,966 | -81,189 | -63,745 |
Net Income | 23,916 | -59,245 | -114,311 | -89,017 |
Net Change In Cash | 6,513 | 61,800 | 85,757 | 64,359 |
Free Cash Flow | -35,831 | -29,383 | -65,162 | -102,353 |
Cash | 5,569 | 19,968 | 29,474 | 29,295 |
Basic Shares | 6,478 | 1,548 | 1,163 | 910 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$200 |
2024-03-31 | -$0.20 |
2023-12-31 | -$0.20 |
2023-06-30 | $0.25 |
